Healthcare & Medical Devices Global On demand · 24-48h

Global Hydrophilic Intermittent Urinary Catheter Market Strategic Research Report

Global Hydrophilic Intermittent Urinary Catheter Market Stra…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Hydrophilic Intermittent Urinary Catheter Market
$5.63B2025
11.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Ready-to-use, Water-activated Type

By Application: Neurogenic Bladder, Postoperative/Acute Urinary Retention, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Becton Dickinson, Convatec, Wellspect, Hollister Incorporated, Teleflex, Well Lead Medical Co., Ltd., Coloplast, Boen Healthcare Co., Ltd, Bevermedical, AdvaCare Pharma, GCMEDICA, Bonree Medical Co., Ltd, Manfred Sauer GMBH, Otsuka Pharmaceutical Factory, Inc., Daxan

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 123 pages
Market size 2025
$5.63B
Billion USD
Forecast CAGR
11.2%
2025-2032
Forecast 2032
$11.8B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Hydrophilic Intermittent Urinary Catheter market size is predicted to grow from US$ 5,635 million in 2025 to US$ 11,807 million in 2032; it is expected to grow at a CAGR of 11.2% from 2026 to 2032.

In 2025, global sales of hydrophilic intermittent urinary catheters reached 1.8 billion units, with an average selling price of US$3.2 per unit. Hydrophilic intermittent urinary catheters are disposable medical consumables with a hydrophilic coating. Before use, they form a lubricating layer upon contact with water, significantly reducing insertion friction and minimizing the risk of urethral injury and infection. They are widely used for patients with neurogenic bladder, postoperative voiding disorders, and those requiring long-term voiding management. Upstream raw materials mainly include medical-grade PVC or TPU tubing, hydrophilic coating materials (PVP, etc.), lubricants, and sterile packaging materials. Downstream supply relationships are primarily with hospital urology departments, rehabilitation institutions, and home care channels. In 2025, global total production capacity was approximately 2.2 billion units, with an industry average capacity utilization rate of approximately 82% and an overall gross profit margin of approximately 40%. Demand and opportunity analysis shows that the accelerated aging of the global population, the increase in patients with neurological diseases and chronic urinary dysfunction, and the increased emphasis on quality of life and infection control are continuously driving the demand for hydrophilic intermittent urinary catheters. In the future, there are clear long-term growth and high-value-added business opportunities in terms of high-comfort design, models specifically for women and children, and expansion into home care channels.

The hydrophilic intermittent urinary catheter market is experiencing steady growth, driven by an aging population, an increasing number of patients with chronic urinary dysfunction, and growing emphasis on infection control and patient comfort in healthcare institutions. Compared to traditional catheters, the hydrophilic coating significantly reduces insertion friction and the risk of urinary tract infections, making it a standard choice in hospitals, rehabilitation facilities, and home care.

Future market competition will focus on product comfort, material safety, and functional diversification, including innovative products such as women's-specific, children's-specific, and visualized catheters. High-end coating technology and the convenience of single-use will be key to enhancing brand recognition and customer loyalty. With the development of home care, chronic disease management, and telemedicine, the hydrophilic intermittent urinary catheter market has enormous potential beyond hospitals, exhibiting sustained growth and high-value-added upgrade potential in the long term, making it an important sub-segment of the urological consumables field.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hydrophilic Intermittent Urinary Catheter market?

What factors are driving Hydrophilic Intermittent Urinary Catheter market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hydrophilic Intermittent Urinary Catheter market opportunities vary by end market size?

How does Hydrophilic Intermittent Urinary Catheter break out by Type, by Application?

This report presents a comprehensive overview of the global Hydrophilic Intermittent Urinary Catheter market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Ready-to-use
  • Water-activated Type

Segment by Material

  • Polyvinyl Chloride Catheters
  • Medical-grade Silicone Catheters
  • Polyurethane Catheters

Segment by Sizes

  • Sizes: 6Fr - 10Fr
  • Sizes: 12Fr - 14Fr
  • Others

Segment by Application

  • Neurogenic Bladder
  • Postoperative/Acute Urinary Retention
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Hydrophilic Intermittent Urinary Catheter market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Neurogenic Bladder, Postoperative/Acute Urinary Retention, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Hydrophilic Intermittent Urinary Catheter Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 11.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$5.63B
2025
Forecast
$11.8B
2032
CAGR
11.2%
2025–2032
Regions
5
global
Key companies
Becton DickinsonConvatecWellspectHollister IncorporatedTeleflexWell Lead Medical Co., Ltd.ColoplastBoen Healthcare Co., Ltd
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Ready-to-useWater-activated Type
By Application
Neurogenic BladderPostoperative/Acute Urinary RetentionOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Ready-to-use
  • 3.1.3 Water-activated Type
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Neurogenic Bladder
  • 4.1.3 Postoperative/Acute Urinary Retention
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Becton Dickinson
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Convatec
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Wellspect
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Hollister Incorporated
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Teleflex
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Well Lead Medical Co.,Ltd.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Coloplast
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Boen Healthcare Co., Ltd
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Bevermedical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 AdvaCare Pharma
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 GCMEDICA
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Bonree Medical Co., Ltd
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Manfred Sauer GMBH
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Otsuka Pharmaceutical Factory, Inc.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Daxan
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Hydrophilic Intermittent Urinary Catheter market?
The global Hydrophilic Intermittent Urinary Catheter market is estimated at US$ 5.63 billion in 2025 (base year) and is projected to reach US$ 11.81 billion by 2032.
How fast is the Hydrophilic Intermittent Urinary Catheter market expected to grow?
The market is expected to grow at a CAGR of 11.2% from 2026 to 2032, expanding from US$ 5.63 billion in 2025 to US$ 11.81 billion in 2032, roughly 2.1 times its base-year value.
What does the Hydrophilic Intermittent Urinary Catheter market cover?
In 2025, global sales of hydrophilic intermittent urinary catheters reached 1.8 billion units, with an average selling price of US$3.2 per unit. Hydrophilic intermittent urinary catheters are disposable medical consumables with a hydrophilic coating. Before use, they form a lubricating layer upon contact with water, significantly reducing insertion friction and minimizing the risk of urethral injury and infection.
What are the main segments of the Hydrophilic Intermittent Urinary Catheter market by type?
By type, the market is segmented into Ready-to-use and Water-activated Type.
Which applications drive demand in the Hydrophilic Intermittent Urinary Catheter market?
Key applications covered include Neurogenic Bladder, Postoperative/Acute Urinary Retention and Others.
Who are the key players in the Hydrophilic Intermittent Urinary Catheter market?
Key players profiled include Becton Dickinson, Convatec, Wellspect, Hollister Incorporated, Teleflex, Well Lead Medical Co., Coloplast and Boen Healthcare Co., among 15 companies covered in total.
Which regions and countries are covered for Hydrophilic Intermittent Urinary Catheter?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Hydrophilic Intermittent Urinary Catheter market?
The hydrophilic intermittent urinary catheter market is experiencing steady growth, driven by an aging population, an increasing number of patients with chronic urinary dysfunction, and growing emphasis on infection control and patient comfort in healthcare institutions.
Who should buy the Hydrophilic Intermittent Urinary Catheter market report?
The report is intended for manufacturers and solution providers, distributors and end users in Neurogenic Bladder, Postoperative/Acute Urinary Retention and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Hydrophilic Intermittent Urinary Catheter market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.